New study aims to keep macular disease patients on track with eye injections

NCT ID NCT07567898

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a personalized care approach helps patients with chronic macular diseases (like wet age-related macular degeneration and diabetic macular edema) attend their regular eye injection appointments. Many patients skip these vital treatments, risking further vision loss. The study will enroll 200 participants at the Singapore National Eye Centre, randomly assigning some to receive a tailored plan involving consultations with nurses, optometrists, and social workers, while others receive standard care. The goal is to see if the personalized plan improves adherence to treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.